EarningsQ3 2024 Earnings Report

Xeris Pharmaceuticals (2B30) Q3 2024 Earnings Report

0 Followers

DE:2B30 Q3 2024 EPS Results

Actual EPS-€0.10

Consensus EPS-€0.08

Beat/MissMissed by -€0.02

One Year Ago EPS-€0.08

Actual Revenue€48.43M

Expected Revenue€45.91M

Beat/MissBeat by +€2.52M

YoY Revenue Growth+12.31%

QuarterQ3 2024

Date11/08/2024

TimeBefore Open

Conference CallFriday, November 8, 2024

DE:2B30 Upcoming Earnings

Xeris Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:2B30 Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	0.03 / -	0	―
Aug 06, 2026	2026 (Q2)	0.01 / -0.16	-0.009	-1700.00% (-0.15)
May 07, 2026	2026 (Q1)	>-0.01 / <0.01	-0.054	116.67% (+0.06)
Mar 02, 2026	2025 (Q4)	0.02 / 0.05	-0.027	300.00% (+0.08)
Nov 06, 2025	2025 (Q3)	<0.01 / 0.00	-0.098	―
Aug 07, 2025	2025 (Q2)	-0.02 / >-0.01	-0.089	90.00% (+0.08)
May 08, 2025	2025 (Q1)	-0.04 / -0.05	-0.125	57.14% (+0.07)
Mar 06, 2025	2024 (Q4)	-0.05 / -0.03	-0.089	70.00% (+0.06)
Nov 08, 2024	2024 (Q3)	-0.08 / -0.10	-0.08	-22.22% (-0.02)
Aug 08, 2024	2024 (Q2)	-0.09 / -0.09	-0.125	28.57% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed